Anthem Inc

ANTM

Get informed when a big investor buys or sells

Market Cap$114.59B

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Anthem Inc	16.5	1.74%	13%	-	-

Earnings Call Q1 2026

April 22, 2026 - AI Summary

First Quarter Performance: Elevance Health reported adjusted diluted earnings per share of $12.58 for Q1 2026, exceeding expectations due to favorable claims experience and seasonality effects in the Individual ACA business, along with $1 per share from nonrecurring investment income. Membership grew to 45.4 million, up 200,000 year-over-year, largely driven by commercial fee-based membership.

Revised Earnings Guidance: The company raised its full-year adjusted diluted earnings per share guidance to at least $26.75, based on strong first-quarter results and an improved operating outlook. They anticipate a return to at least 12% adjusted EPS growth for 2027.

Medicaid Margins and Member Decline: Medicaid performance is slightly better than expectations, contributing to the overall operating results, with margins projected at approximately negative 1.75% for the year. Initially anticipated high single-digit percentage declines in Medicaid membership may accelerate throughout the year, but results for Q1 show only a 1.5% decrease (excluding growth in Indiana).

Exclusive for Stockcircle Pro members

$501.77

Current Fair Value

4% upside

Undervalued by 4% based on the discounted cash flow analysis.

Share Statistics

Market cap	$114.59 Billion
Enterprise Value	$106.01 Billion
Dividend Yield	$29.00 (1.74%)
Earnings per Share	$25.28
Beta	0.97
Outstanding Shares	0

Return

Return on Equity	13.15%
Return on Assets	4.59%
Return on Invested Capital	102.40%

Valuation & Multiples

P/E Ratio	16.54
PEG	-85.34
Price to Sales	-
Price to Book Ratio	-
Enterprise Value to Revenue	0.5
Enterprise Value to EBIT	1.29
Enterprise Value to Net Income	18
Total Debt to Enterprise	0.01
Debt to Equity	0.02

Revenue Sources

No data

Insider Trades

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Anthem Inc

CEO: Gail Boudreaux

Relevant Senate Committees

Finance

This is a pivotal committee for Anthem, controlling taxation, trade, and crucial entitlement spending programs (Medicare, Medicaid). Its legislative decisions on these matters directly impact Anthem's profitability, market opportunities, and regulatory landscape.

Appropriations

This committee directly allocates federal spending to health programs like Medicare, Medicaid, and other government healthcare initiatives. Its decisions directly determine funding and revenue streams for Anthem, which administers or participates in these programs.

Health, Education, Labor, and Pensions

This committee has direct jurisdiction over federal health policy, drug approval (FDA), and labor laws (e.g., ACA, ERISA), all of which profoundly impact the regulatory environment, operational costs, and product offerings of health insurers like Anthem.